Type I IFN-induced, NKT cell-mediated negative control of CD8 T cell priming by dendritic cells

被引:17
作者
Bochtler, Petra [1 ]
Kroeger, Andrea [2 ]
Schirmbeck, Reinhold [1 ]
Reimann, Joerg [1 ]
机构
[1] Univ Ulm, Dept Internal Med 1, D-7900 Ulm, Germany
[2] Helmholtz Ctr Infect Res, Braunschweig, Germany
关键词
D O I
10.4049/jimmunol.181.3.1633
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated the negative effect of type I IFN (IFN-I) on the priming of specific CD8 T cell immunity. Priming of murine CD8 T cells is down-modulated if Ag is codelivered with IFN-I-inducing polyinosinic:polycytidylic acid (pI/C) that induces (NK cell- and T/B cell-independent) acute changes in the composition and surface phenotype of dendritic cells (DC). In wild-type but not IFN-I receptor-deficient mice, pI/C reduces the plasmacytoid DC but expands the CD8(+) conventional DC (cDC) population and up-regulates surface expression of activation-associated (CD69, BST2), MHC (class I/II), costimulator (CD40, CD80/CD86), and coinhibitor (PD-L1/L2) molecules by cDC. Naive T cells are efficiently primed in vitro by IFN-I-stimulated CD8 cDC (the key APC involved in CD8 T cell priming) although these DC produced less IL-12 p40 and IL-6. pI/C (IFN-I)-mediated down modulation of CD8 T cell priming in vivo was not observed in NKT cell-deficient CD1d(-/-) mice. CD8 cDC from pI/C-treated mice inefficiently stimulated IFN-gamma, IL-4, and IL-2 responses of NKT cells. In vitro, CD8 cDC that had activated NKT cells in the presence of IFN-I primed CD8 T cells that produced less IFN-gamma but more IL-10. The described immunosupressive effect of IFN-I thus involves an NKT cell-mediated change in the phenotype of CD8 cDC that favors priming of IL-10-producing CD8 T cells. In the presence of IFN-I, NKT cells hence impair the competence of CD8 cDC to prime proinflammatory CD8 T cell responses.
引用
收藏
页码:1633 / 1643
页数:11
相关论文
共 59 条
[41]   Interleukin 12-dependent interferon γ production by CD8α+ lymphoid dendritic cells [J].
Ohteki, T ;
Fukao, T ;
Suzue, K ;
Maki, C ;
Ito, M ;
Nakamura, M ;
Koyasu, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (12) :1981-1986
[42]   Antiproliferative action of interferon-alpha requires components of T-cell-receptor signalling [J].
Petricoin, EF ;
Ito, S ;
Williams, BL ;
Audet, S ;
Stancato, LF ;
Gamero, A ;
Clouse, K ;
Grimley, P ;
Weiss, A ;
Beeler, J ;
Finbloom, DS ;
Shores, EW ;
Abraham, R ;
Larner, AC .
NATURE, 1997, 390 (6660) :629-632
[43]   Mechanisms of type-I- and type-II-interferon-mediated signalling [J].
Platanias, LC .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (05) :375-386
[44]   CD1d1-dependent control of the magnitude of an acute antiviral immune response [J].
Roberts, TJ ;
Lin, YL ;
Spence, PM ;
Van Kaer, L ;
Brutkiewicz, RR .
JOURNAL OF IMMUNOLOGY, 2004, 172 (06) :3454-3461
[45]   DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope [J].
Robertson, JM ;
Jensen, PE ;
Evavold, BD .
JOURNAL OF IMMUNOLOGY, 2000, 164 (09) :4706-4712
[46]   Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross-reactive, natural HBsAg variants [J].
Schirmbeck, R ;
Dikopoulos, N ;
Kwissa, M ;
Leithäuser, F ;
Lamberth, K ;
Buus, S ;
Melber, K ;
Reimann, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (12) :3342-3352
[47]   Different immunogenicity of H-2Kb-restricted epitopes in natural variants of the hepatitis B surface antigen [J].
Schirmbeck, R ;
Böhm, W ;
Fissolo, N ;
Melber, K ;
Reimann, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (09) :2429-2438
[48]   CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs [J].
Shiow, LR ;
Rosen, DB ;
Brdicková, N ;
Xu, Y ;
An, JP ;
Lanier, LL ;
Cyster, JG ;
Matloubian, M .
NATURE, 2006, 440 (7083) :540-544
[49]   Steady-state and inflammatory dendritic-cell development [J].
Shortman, Ken ;
Naik, Shalin H. .
NATURE REVIEWS IMMUNOLOGY, 2007, 7 (01) :19-30
[50]   Type I interferons in host defense [J].
Stetson, Daniel B. ;
Medzhitov, Ruslan .
IMMUNITY, 2006, 25 (03) :373-381